Brief introduction of Livzon Group (0005 13). Livzon Pharmaceutical Group Co., Ltd. is a comprehensive enterprise group integrating pharmaceutical R&D, production and sales. Founded in June, 1985, 1. It is connected with Hong Kong waterway and Macao land, and it is two hours' drive from Guangzhou and Shenzhen, with obvious geographical advantages. The registered capital of the company is 306 million yuan, which is a privately-held listed company. Livzon Group completed the shareholding system reform on 1993 and became the first A-share and B-share listed company in the national pharmaceutical industry. The Group has 12 wholly-owned subsidiaries and 10 holding enterprises with 5,000 employees. Employees with college education or above account for 83% of the total number of the group. The enterprise has strong technical force, excellent equipment and advanced technology, and its production level and quality level are in the leading position in the industry. The 53 production lines of the Group passed GMP certification and acceptance, and the marketing enterprises successfully passed the national GSP certification, and their marketing power was significantly enhanced. Livzon Pharmaceutical Group has established a marketing network covering the domestic market, and established stable and good business relations with major commercial channels and thousands of hospitals. With the continuous improvement of the quality system, the rapid growth of sales, the continuous expansion of production capacity and the acceleration of the construction of new factories, Livzon Group will become a leading domestic and world-class modern pharmaceutical leading enterprise.
On March 6, 20 14, Zhuhai Livzon McAb Biotechnology Co., Ltd., a joint venture subsidiary of Livzon Group and Healthy Yuan, obtained the approval number of the national (SFDA) for recombinant humanized anti-tumor necrosis factor α monoclonal antibody for injection.
With the care of the Party, * * and the public, and with the joint efforts of all employees, Livzon Pharmaceutical Group has been among the top 500 industrial enterprises in China for many years since 1989. Since 1995, it has been ranked among the top 50 pharmaceutical industries in China; 1996 was recognized by the state science and technology commission as 76 key high-tech enterprises in the torch plan and listed as 70 large enterprise groups in Guangdong province. 1999 was recognized as an enterprise with technological innovation advantages by Guangdong province; The registered trademark of Livzon was confirmed as "China Famous Trademark" 1999 1 by the State Trademark Office in June. In June 2002, Livzon Pharmaceutical Group was born in changes in equity, and now it is Shenzhen Health Yuan Group, becoming the largest shareholder of Livzon. Two well-known enterprises in the field of medicine and health achieved a strong alliance, set up a company's senior management team headed by the famous entrepreneur Zhu, and started a brand-new second venture. Livzon is at the forefront of the industry with its own exploration and practice of reform and innovation.